Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2023 17:51 ET | Source: DiaCarta, Ltd.

DiaCarta Receives Accreditation by the College of American Pathologists (CAP)

PLEASNTON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious diseases, today announced that it has received...
April 16, 2023 14:00 ET | Source: DiaCarta, Ltd.

DiaCarta Announces Five Abstracts Accepted for Presentation at AACR Annual Meeting 2023

Abstracts demonstrating XNA technology’s improvements to assay sensitivity across different technology platforms and support for use in companion diagnostics (CDx) assay developmentAdditional...
January 12, 2023 08:30 ET | Source: DiaCarta, Ltd.

DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit

PLEASANTON, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) granted...
January 05, 2023 08:00 ET | Source: DiaCarta, Ltd.; Nonagen Bioscience

DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience

DiaCarta Starts to Receive Samples for Oncuria® Bladder Cancer Test at its CLIA Lab PLEASANTON, Calif. and LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a precision...